INTERNATIONAL PATENT: ASTELLAS US LLC, CYTOMX THERAPEUTICS, INC., SATO, MASAHITO, KIKUCHI, AYA FILES APPLICATION FOR "BISPECIFIC ANTIBODIES THAT BIND CD3 AND MUC1 AND METHODS OF USE THEREOF"

GENEVA, Feb. 4 -- ASTELLAS US LLC (2375 Waterview DriveNorthbrook, IL 60062), CYTOMX THERAPEUTICS, INC. (151 Oyster Point Blvd., Suite 400South San Francisco, CA 94080), SATO, Masahito (2375 Waterview DriveNorthbrook, IL 60062), KIKUCHI, Aya (2375 Waterview DriveNorthbrook, IL 60062) filed a patent application (PCT/US2025/038857) for "BISPECIFIC ANTIBODIES THAT BIND CD3 AND MUC1 AND METHODS OF USE THEREOF" on Jul 23, 2025. With publication no. WO/2026/024841, the details related to the patent application was published on Jan 29, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BOUSTANY, Leila...